The next step for taribavirin

Authors

  • Paul Y. Kwo M.D.,

    Corresponding author
    1. Division of Gastroenterology and Hepatology Indiana University School of Medicine Indianapolis, IN
    • Division of Gastroenterology and Hepatology, Indiana University School of Medicine, 975 West Walnut Street, IB 327, Indianapolis, IN 46202-5121
    Search for more papers by this author
    • fax: 317-274-3106

  • Rakesh Vinayek M.B.B.S.

    1. Division of Gastroenterology and Hepatology Indiana University School of Medicine Indianapolis, IN
    Search for more papers by this author

  • See Article on Page 1208

  • Potential conflict of interest: Dr. Kwo advises, is on the speakers' bureau of, and received grants from Merck and Gilead. He advises and received grants from Vertex, Abbott, and Human Genome Sciences. He advises Novartis and Anadys. He is on the speakers' bureau of Roche and Bristol-Myers Squibb. He advises and is on the speakers' bureau of Salix. He also received grants from Tibotec, Valeant, Eisai and Asic. Dr. Vinayek is on the speakers' bureau of Merck and Genetech. He received grants from Pfizer and Celgene.

Ancillary